The First Naturopathic-Quality Milk Thistle

(Ref20C15)
Effect of Siliphos® on chronic active hepatitis:
Study shows significant reduction in elevated liver enzymes (and therefore hepatocellular necrosis) in just one week of treatment with Siliphos®.

(Ref21C13)
Therapeutic effect of Siliphos® in chronic liver disease:
A small study of eight human subjects with chronic active hepatitis. This study shows significant benefits of Siliphos® after just two months treatment.

(Ref8P22)
Direct comparison of Siliphos® to standardized milk thistle extract:
Study shows nearly 10x the bioavailability of Siliphos® over the world’s best selling standardized extract.

(Ref18C14)
Useful dosages of Siliphos®:
Shows definite advantages of Siliphos® at dosages ranging from 160mg to 360mg (measured as silybin). Dose/effect relationship is also demonstrated with the highest dosage tested getting the most dramatic results.

(c10)
Greater bioavialability of silybin as a component of Siliphos®:
Laboratory study shows that binding silybin with phosphatidylcholine on a molecular level dramatically improves its bioavailablity on a cellular level.

(c3medline)
Increased oral bioavailability of Siliphos® in humans:
Human study compares Siliphos® and the worlds best selling standardized milk thistle extract and shows how much better the results are with Siliphos®.

(Ref9C8)
Effect of Siliphos® on cirrhotic patients:
Study shows that Siliphos® does not significantly differ in its safe and beneficial activity in patients with cirrhosis vs. healthy control subjects.

(Ref10C2)
Long term usage of Siliphos®:
Study shows the beneficial properties of Siliphos® are not diminshed by sustained usage of the product.

(Ref12P19)
Liver damage control properties of Siliphos®:
Siliphos® shows significant protective activity against liver damage. This study tested Siliphos® protection against a variety of toxins.

(Ref13P6)
Free radical scavenging properties of Siliphos®:
Study shows the capability of Siliphos® to scavenge free radicals and inhibit lipid peroxidation. It also demonstrates significantly higher blood plasma levels of silybin when administered as a component of Siliphos® rather than in its unbound form.

(Ref14P13)
Effect of silimarin on lipid peroxidation:
Study shows milk thistle extract (silymarin) to be a helpful antioxidant and silybin to be the most valuable constituent of silymarin.

(Ref15P16)
Siliphos® counteracts hepatotoxic effects:
Study shows Siliphos® protects liver cells against free-radical mediated toxic liver injury.

(Ref16P23)
Antioxidant activity of Siliphos® against alcohol:
Study shows how Siliphos® is dramatically more effective than pure silybin alone. Concludes Siliphos® may be useful in counteracting damage caused by alcohol intake.

(Ref19C6)
Tolerablility and effectiveness of Siliphos®:
Study shows high dose tolerability of Siliphos® as well as its increased effectiveness over conventional standardized milk thistle extract.

(c6medline)
Liver protection potential of Siliphos®:
Study shows the antioxidant and free radical scavenging effect of Siliphos®.

(Ref7P12)
Comparative bioavailability of Siliphos® vs. silybin:
Study shows exactly how much better silybin is absorbed when combined on a molecular level with phosphatidylcholine (a patented process resulting in Siliphos®).

(Ref11P1)
Liver protective activity:
Shows Siliphos® is more effective than its constituents, silybin and phosphatidylcholine, alone. The effectiveness of Siliphos® is considerably greater than the sum of its parts.